Pharma R&D Spending Falls for the First Time

Spending cuts by big pharma companies has led to the global pharma industry’s first ever annual fall in R&D spending, according to research by Thomson Reuters. The sector’s R&D spending fell by nearly 3% to $68 billion in 2010, when compared with the year earlier. The trend is set to continue again this year, Thomson Reuters says. The drop in R&D expenditure reflects a fall in innovation for each dollar invested. Research spending by drug companies accounting for 80% of the industry's total R&D has increased by more than 50% since...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers